Cargando…
PPARγ Agonists in Adaptive Immunity: What Do Immune Disorders and Their Models Have to Tell Us?
Adaptive immunity has evolved as a very powerful and highly specialized tool of host defense. Its classical protagonists are lymphocytes of the T- and B-cell lineage. Cytokines and chemokines play a key role as effector mechanisms of the adaptive immunity. Some autoimmune and inflammatory diseases a...
Autores principales: | da Rocha Junior, Laurindo Ferreira, Dantas, Andréa Tavares, Duarte, Ângela Luzia Branco Pinto, de Melo Rego, Moacyr Jesus Barreto, Pitta, Ivan da Rocha, Pitta, Maira Galdino da Rocha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747405/ https://www.ncbi.nlm.nih.gov/pubmed/23983678 http://dx.doi.org/10.1155/2013/519724 |
Ejemplares similares
-
The Role of PPAR Gamma in Systemic Sclerosis
por: Dantas, Andréa Tavares, et al.
Publicado: (2015) -
Galectin-9 gene (LGALS9) polymorphisms are associated with rheumatoid arthritis in Brazilian patients
por: Vilar, Kamila de Melo, et al.
Publicado: (2019) -
Synthesis of a Novel Thiazolidinedione and Evaluation of Its Modulatory Effect on IFN-γ, IL-6, IL-17A, and IL-22 Production in PBMCs from Rheumatoid Arthritis Patients
por: da Rocha Junior, Laurindo Ferreira, et al.
Publicado: (2013) -
Galectin-1, -4, and -7 Were Associated with High Activity of Disease in Patients with Rheumatoid Arthritis
por: Vilar, Kamila de Melo, et al.
Publicado: (2019) -
Interleukin-18 in Brazilian Rheumatoid Arthritis Patients: Can Leflunomide Reduce It?
por: Gualberto Cardoso, Pablo Ramon, et al.
Publicado: (2021)